Departamento de Farmacoloxía, Farmacia e Tecnoloxía Farmacéutica
Institut
University of Eastern Finland
Kuopio, FinlandiaPublikationen in Zusammenarbeit mit Forschern von University of Eastern Finland (21)
2024
-
Discovery and in vitro Evaluation of Novel Serotonin 5-HT2A Receptor Ligands Identified Through Virtual Screening
ChemMedChem, Vol. 19, Núm. 14
2023
-
Development and Characterization of Novel Selective, Non-Basic Dopamine D2 Receptor Antagonists for the Treatment of Schizophrenia
Molecules, Vol. 28, Núm. 10
-
Discovery of novel arylpiperazine-based DA/5-HT modulators as potential antipsychotic agents – Design, synthesis, structural studies and pharmacological profiling
European Journal of Medicinal Chemistry, Vol. 252
-
Novel multi-target ligands of dopamine and serotonin receptors for the treatment of schizophrenia based on indazole and piperazine scaffolds-synthesis, biological activity, and structural evaluation
Journal of enzyme inhibition and medicinal chemistry, Vol. 38, Núm. 1, pp. 2209828
2022
-
Allosteric modulation of dopamine D2L receptor in complex with Gi1 and Gi2 proteins: the effect of subtle structural and stereochemical ligand modifications
Pharmacological Reports, Vol. 74, Núm. 2, pp. 406-424
-
In vitro and in vivo evaluation of antioxidant and neuroprotective properties of antipsychotic D2AAK1
Neurochemical Research, Vol. 47, Núm. 6, pp. 1778-1789
-
Multitarget Derivatives of D2AAK1 as Potential Antipsychotics: The Effect of Substitution in the Indole Moiety
ChemMedChem, Vol. 17, Núm. 15
-
Understanding dexamethasone kinetics in the rabbit tear fluid: Drug release and clearance from solution, suspension and hydrogel formulations
European Journal of Pharmaceutics and Biopharmaceutics
2021
-
Current Situation and Challenges in Vitreous Substitutes
Macromolecular Bioscience, Vol. 21, Núm. 8
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
N-(3-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}propyl)-1H-indazole-3-carboxamide (D2AAK3) as a potential antipsychotic: In vitro, in silico and in vivo evaluation of a multi-target ligand
Neurochemistry International, Vol. 146
2020
-
N-(2-hydroxyphenyl)-1-[3-(2-oxo-2,3-dihydro-1h-benzimidazol-1-yl)propyl]piperidine-4-carboxamide (d2aak4), a multi-target ligand of aminergic gpcrs, as a potential antipsychotic
Biomolecules, Vol. 10, Núm. 2
-
PET study of ocular and blood pharmacokinetics of intravitreal bevacizumab and aflibercept in rats
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 154, pp. 330-337
2019
-
Synthesis, pharmacological and structural studies of 5-substituted-3-(1-arylmethyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as multi-target ligands of aminergic GPCRs
European Journal of Medicinal Chemistry, Vol. 180, pp. 673-689
2018
-
Synthesis, Structural and Thermal Studies of 3-(1-Benzyl-1,2,3,6-tetrahydropyridin-4-yl)-5-ethoxy-1H-indole (D2AAK1_3) as Dopamine D₂ Receptor Ligand
Molecules (Basel, Switzerland), Vol. 23, Núm. 9
2016
-
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356
Autophagy
-
Erratum: Corrigendum to “In vitro, molecular modeling and behavioral studies of ‘3-{[4-(5-methoxy-1H-indol-3-yl)-1,2,3,6-tetrahydropyridin-1-yl]methyl}-1,2-dihydroquinolin-2-one (D2AAK1) as a potential antipsychotic” (Neurochemistry International (2016) 96 (84–99)(10.1016/j.neuint.2016.03.003)(S0197018616300304))
Neurochemistry International
-
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Autophagy, Vol. 12, Núm. 1, pp. 1-222
-
In vitro, molecular modeling and behavioral studies of 3-{[4-(5-methoxy-1H-indol-3-yl)-1,2,3,6-tetrahydropyridin-1-yl]methyl}-1,2-dihydroquinolin-2-one (D2AAK1) as a potential antipsychotic
Neurochemistry International, Vol. 96, pp. 84-99
-
Structure-Based Virtual Screening for Dopamine D2 Receptor Ligands as Potential Antipsychotics
ChemMedChem, Vol. 11, Núm. 7, pp. 718-729